Topotecan: a new topoisomerase I inhibiting antineoplastic agent.

Cersosimo, R J

Cersosimo, R J.

Affiliation

Cersosimo RJ; Bouvé College of Pharmacy & Health Sciences, Northeastern University, Boston, MA 02115, USA. r.cersosimo@nunet.neu.edu

Ann Pharmacother ; 32(12): 1334-43, 1998 Dec.

Article in En | MEDLINE | ID: mdl-9876816

Subject(s)

Antineoplastic Agents/therapeutic use; Enzyme Inhibitors/therapeutic use; Neoplasms/drug therapy; Topoisomerase I Inhibitors; Topotecan/therapeutic use; Antineoplastic Agents/economics; Antineoplastic Agents/pharmacokinetics; Clinical Trials as Topic; Economics, Pharmaceutical; Enzyme Inhibitors/economics; Enzyme Inhibitors/pharmacokinetics; Humans; Topotecan/economics; Topotecan/pharmacokinetics; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Topotecan / Enzyme Inhibitors / Topoisomerase I Inhibitors / Neoplasms / Antineoplastic Agents Type of study: Health_economic_evaluation Limits: Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links